| P2093 | author name string | R Sanz | |
| | A Carvajal | |
| | L H Martín Arias | |
| | M Sáinz | |
| | C Treceño | |
| P2860 | cites work | Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine | Q70771999 |
| | Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001 | Q85022814 |
| | Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis | Q22241939 |
| | Guillain–Barré Syndrome | Q22248108 |
| | Meta-analysis in clinical trials | Q27860779 |
| | Guillain-Barré syndrome after exposure to influenza virus | Q28291850 |
| | Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study | Q28751886 |
| | Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011. | Q30351998 |
| | Evaluating the safety of influenza vaccine using a claims-based health system. | Q30354805 |
| | Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe | Q30357675 |
| | Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany | Q30362413 |
| | Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database. | Q30373486 |
| | Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. | Q30376061 |
| | Guillain-barré syndrome following influenza vaccination: causal or coincidental? | Q30403959 |
| | Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe | Q30404728 |
| | Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series | Q30406477 |
| | Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus | Q30413197 |
| | Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System, 2009-2010. | Q30416712 |
| | Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec | Q30419053 |
| | Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review | Q30421760 |
| | Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. | Q30423780 |
| | Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis | Q30428338 |
| | Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study | Q30428839 |
| | International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines | Q30431960 |
| | Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database. | Q33280997 |
| | Tutorial in biostatistics: the self-controlled case series method | Q33368891 |
| | Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976--1977 | Q34215590 |
| | Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination | Q34278694 |
| | Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). | Q34640979 |
| | In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases | Q34700616 |
| | Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome | Q34784351 |
| | Vaccines and Guillain-Barré syndrome | Q34977408 |
| | Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England. | Q35793527 |
| | Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination | Q36902462 |
| | Guillain-Barre syndrome during the 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans | Q37463235 |
| | Guillain-barré syndrome: modern theories of etiology. | Q37859643 |
| | Risk of confirmed Guillain-Barre syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the Vaccine Safety Datalink Project, 2009-2010. | Q38009803 |
| | Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. | Q38104881 |
| | Guillain-Barre syndrome, influenzalike illnesses, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. | Q38438386 |
| | Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions | Q39157513 |
| | Guillain-Barré syndrome associated with Campylobacter jejuni infection in England, 2000-2001. | Q39507470 |
| | Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study | Q43823253 |
| | Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season | Q45162452 |
| | Lack of association of Guillain-Barré syndrome with vaccinations | Q45873093 |
| | Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination | Q48462064 |
| | The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. | Q50852734 |
| | Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. | Q51849672 |
| | The risk of Guillain-Barré syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. | Q53645955 |
| | No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000 | Q57388524 |
| | Guillain-Barré Syndrome After Influenza Vaccination in Adults | Q57661024 |
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | influenza vaccine | Q383260 |
| | meta-analysis | Q815382 |
| | Guillain–Barré syndrome | Q205214 |
| P304 | page(s) | 3773-3778 | |
| P577 | publication date | 2015-05-18 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Guillain-Barré syndrome and influenza vaccines: A meta-analysis. | |
| P478 | volume | 33 | |